Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...
Jan 30 (Reuters) - Dr. Lal Path Labs (DLPA.NS), opens new tab reported a lower third-quarter profit on Friday after taking a one-time charge linked to India’s new labour code, despite strong demand ...
Dr Lal Path Labs, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid rising ...
Earnings call Dr. Lal PathLabs reported Q3 FY26 revenue of ₹660 crore, up 10.6% YoY, supported by a 7.7% rise in revenue per patient. EBITDA margin (pre-exceptional) improved to 27.2%. While patient ...
Add Yahoo as a preferred source to see more of our stories on Google. Jan 30 (Reuters) - Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results